USA flag logo/image

An Official Website of the United States Government

Integrin Targeted Therapy for the Treatment of Ovarian Cancer

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
R43DA037588
Solicitation Year:
2013
Solicitation Topic Code:
NIDA
Solicitation Number:
PA13-088
Small Business Information
BIOSPEECH, INC.
940 UPPER DEVON LANE LAKE OSWEGO, OR 97034-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2013
Title: Integrin Targeted Therapy for the Treatment of Ovarian Cancer
Agency: HHS
Contract: 1R43DA037588-01A1
Award Amount: $234,295.00
 

Abstract:

Summary Sleep disordered breathing (SDB) is believed to be a widespread, under-diagnosed condition associated with detrimental health problems, at a high cost to society. The current gold standard for diagnosis of SDB is a time- consuming, expensive, and obtrusive (requiring many attached wires) sleep study, or polysomnography (PSG). The immediate objective of the proposed research is to develop and evaluate a hardware design and a set of algorithms for automatically detecting obstructive, central, or mixedapneas and hypopneas from acoustic, peripheral oxygen saturation (SpO2), and pulse rate data, using an ambient microphone and a wireless pulse oximeter. The long-term goal is to create a low-cost, easy-to-operate, minimally obtrusive, at-home device thatcan be used to screen for SDB in patients' homes. Our specific aims are to: (1) develop a screening system by selecting minimally obtrusive sensor hardware and extending state-of-the art algorithms for automatically detecting SDB from acoustic, SpO2, andpulse rate data; (2) collect patient data in the sleep lab and at home from representative populations using the proposed system; (3) determine the screening accuracy by comparing the performance of the proposed system on the collected data against standard PSG-derived clinical results; and (4) measure the usability of an at-home screening device by the target population, by asking subjects who participated in the at-home data collection to complete a survey on various aspects of the setup and operation ofthe proposed system. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The proposed work will create a portable, low-cost, and minimally obtrusive system for automatically detecting sleep-disordered breathing, such as cessation of breathing (apnea). The system will enable early and frequent screening for sleep-disordered breathing in a patient's home, significantly increasing patient comfort while cap- turing more representative sleep data compared to a clinical sleep study requiring many attached wires.

Principal Investigator:

Brian R. Snider
971-222-6550
sniderb@biospeech.com

Business Contact:

Michele Webber
503-707-1291
webberm@biospeech.com
Small Business Information at Submission:

BIOSPEECH, INC.
940 UPPER DEVON LANE LAKE OSWEGO, OR 97034-

EIN/Tax ID: 120088361
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No